Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04844723 Completed - Anesthesia Clinical Trials

Pediatric Videolaryngoscopic Intubation and Difficult Airway Classification

PeDiAC
Start date: April 12, 2021
Phase:
Study type: Observational

The study's primary aim is to develop and validate a multivariable diagnostic model for the prediction of difficult videolaryngoscopy (the 'PeDiAC classification') in children undergoing general anesthesia with tracheal intubation. The secondary aim is to compare the diagnostic performance of the PeDiAC-classification with the Cormack-Lehane classification.

NCT ID: NCT04844489 Completed - Multiple Sclerosis Clinical Trials

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

COVIVAC-ID
Start date: April 16, 2021
Phase: N/A
Study type: Interventional

Prospective, multicenter, non-comparative cohort study of immunocompromised people vaccinated against Covid-19 with the aim to know the humoral and cellular response to BNT162b2 vaccination against SARS-CoV-2 variants. This study will enroll patients in 5 parallel sub-cohorts of the same size, distinct according to the source of the immunosuppression: autoimmune or auto-inflammatory disease, HIV infection, multiple sclerosis, solid cancer, organ transplantation with prospective data collection and constitution of biological collections.

NCT ID: NCT04842734 Completed - Alzheimer Disease Clinical Trials

Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease

Start date: April 27, 2021
Phase: N/A
Study type: Interventional

Our aim has been determined to investigate the effect of physical exercise alone and in combination with cognitive exercise, on cognitive, physical function and quality of life in individuals with Alzheimer's Disease during the Covid-19 pandemic period.

NCT ID: NCT04842578 Completed - Segmentectomy Clinical Trials

The Guidance of Thin Cross- Section of CT in Anatomic Segmentectomy

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

Three-dimensional (3D) simulation of pulmonary vessels and the space between the lesion and adjacent tissues is regarded improving the safety and accuracy of video-assisted thoracoscopic surgery (VATS) for segmentectomy for ground glass opacity (GGO) in lung. However, not every thoracic surgeon can handle the technique, in addition, the 3D reconstruction originate from the thin CT scan. Actually, the investigators found that, the reading and comprehension of the thin cross- section of CT can guide the accurate anatomic segmentectomy in most situations. The investigators designed a retrospective study to compare the reading of thin cross- section of CT with 3D reconstruction or without 3D reconstruction during the guidance of anatomic segmentectomy.

NCT ID: NCT04842136 Completed - Headache Clinical Trials

Factors Affecting Patients With Myofascial Temporomandibular Disorders

Start date: January 13, 2020
Phase:
Study type: Observational

The aim of the study was to assess and compare the relationship between jaw function, neck disability, sleep quality, fatigue, and headache in patients with myofascial Temporomandibular Disorder (TMD) with Sleep Bruxism (SB) and without (non-SB).

NCT ID: NCT04841629 Completed - Clinical trials for User Acceptability of Gel Delivery System

Perception & Acceptability of a Cervical Cancer Prevention Prebiotic Device

Start date: February 24, 2022
Phase: N/A
Study type: Interventional

PreBioGyn will be compared to market leading vaginal pH buffering gels using established forearm test methods associated with vaginal lubricity sensation in 42 women. Women will also rate each gel for smell and appearance using established methods. The PreBioGyn gel enclosure and intravaginal applicator design will be evaluated for: look and feel, ability to prepare for dosing, ability to expulse dose, and likelihood of future use by subjects. Open-ended feedback on the gel and applicator will occur to gather contributions for each product.

NCT ID: NCT04841577 Completed - Clinical trials for Respiratory Syncytial Virus Infections

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above

Start date: April 27, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the immunogenicity, safety and reactogenicity of the RSVPreF3 OA investigational vaccine when co-administered with the seasonal quadrivalent influenza vaccine (FLU-QIV) in adults aged 60 years and above compared to separate administration of the vaccines.

NCT ID: NCT04841330 Completed - Clinical trials for Peripheral Intavenous Catheter Stabilization

Prospective Healthy Volunteer Study of the Securis™ Stabilization Device

Start date: June 9, 2021
Phase:
Study type: Observational

This study is being conducted to assess the performance of the Securis™ Stabilization Device in simulated clinical use.

NCT ID: NCT04841070 Completed - Clinical trials for Persistent Pulmonary Hypertension of the Newborn

NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn

NEUROPHON
Start date: July 25, 2021
Phase: N/A
Study type: Interventional

Neonatal pulmonary hypertension is a rare but serious condition resulting from a lack of adaptation to extra-uterine life in some newborns. In the short term, the risk of death requires rapid and appropriate management of this transient pathology. In the long term, these newborns present a greater brain vulnerability, a consequence of the pathology itself with cerebral hypoxia but also invasive and aggressive therapies. Although current scientific evidence indicates a correlation with the existence of neurological developmental disorders, the understanding of the long-term neurological outcome of these babies remains poorly documented. Better knowledge of remote neuro-psychomotor development of the critical period

NCT ID: NCT04841018 Completed - Clinical trials for Patients With Cryptorchism Who Are Planning to Undergo Orchiopexy

Does Low Dose of Dexamethasone Enhance Analgesic Quality of Caudal Analgesia in Children Undergoing Orchiopexy?

Start date: March 24, 2021
Phase: N/A
Study type: Interventional

Caudal block is one of the most effective modalities to reduce pain both during and after the surgery involving areas under the umbilicus. According to previous research, 0.5mg/kg-1.5mg/kg dexamethasone is known to enhance the analgesic quality of caudal block in children. Despite the fact that this high dose of dexamethasone is used to treat airway edema in actual practice and no adverse side effect related to dosage has been reported, it is 3 to 15 times higher than the daily antiemetic dose of dexamethasone that is used in standard care of anesthesia. Therefore, our study aims to assess the effect of the more practical, antiemetic dose of dexamethasone (0.15mg/kg) as an adjuvant to enhance the quality of caudal block through a non-inferiority trial.